Lv3
380 积分 2021-08-09 加入
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use
15天前
已完结
Prevalence and predictors of high inflammatory risk in heart failure subtypes: findings from the global POSEIDON study
27天前
已关闭
A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness
3个月前
已完结
Pembrolizumab in HER2-Positive Gastric Cancer
8个月前
已完结
China ARCHES: A Phase 3 Trial of Enzalutamide vs Placebo in Metastatic Hormone-Sensitive Prostate Cancer
10个月前
已关闭
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
1年前
已完结
Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
1年前
已完结
Atezolizumab and bevacizumab for HCC in the real world
1年前
已完结
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
1年前
已完结
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
1年前
已完结
皖公网安备34019202002308
